[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607845":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":42,"responsibleParty":67,"collaborators":25,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":25,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":25,"enrollmentInfo":78,"targetDuration":25,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":91,"overallStatus":45,"whyStopped":25,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"King Abdullah Medical City","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"The zinc oxide group","ACTIVE_COMPARATOR","The zinc oxide group will receive topical zinc oxide twice every 12 hours daily",[13],"Drug: zinc oxide",{"label":15,"type":10,"description":16,"interventionNames":17},"MEBO group","patients in the MEBO group will receive topical MEBO ointment twice every 12 daily",[18],"Drug: MEBO Wound Ointment",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","MEBO Wound Ointment","both are used for second pressure ulcer",[15],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"zinc oxide","both are used to treat second degree pressure ulcer but with no superiority",[9],[31],{"name":32,"affiliation":33,"role":34},"Dr. Ebtisam AbdElatif Ebrahim, Master degree of science in nu","King Abdullah Medical City in Holy Capital","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"wedian Almowallad, Master","CONTACT","+96612 5549999","18004","Almwlld.W@kamc.med.sa",[43,62],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"King Abdulla Medical City in Holy capital","RECRUITING","Mecca","Western Reagan","24211","Saudi Arabia","SA",{"type":52,"coordinates":53},"Point",[54,55],39.82563,21.42664,{"lat":55,"lon":54},[58,60],{"name":37,"role":38,"phone":39,"phoneExt":59,"email":41},"Ext: 18004",{"name":61,"role":34,"phone":25,"phoneExt":25,"email":25},"Ebtisam AbdElatif Ebrahim, Master degree of science in nu",{"facility":44,"status":63,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":64,"geoPoint":66,"contacts":25},"COMPLETED",{"type":52,"coordinates":65},[54,55],{"lat":55,"lon":54},{"type":68,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100607845","phase-4-zinc-oxide-vs-mebo-100607845",false,"NCT07193849","Zinc Oxide VS MEBO","Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial","Inclusion Criteria:\n\n* Willing to participate.\n* KAMC cases in medical ward, neuroscience ward, and intensive care unit.\n* Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel\u002Fnational pressure ulcer advisory panel (NPUAP) guidelines.\n\nExclusion Criteria:\n\n* Not consenting to participate\n* Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients.\n* Either a category III or IV pressure ulcer.\n* Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage).\n* Signs of wound infection (pus draining from the ulcer, a foul-smelling odour, tenderness, heat and increased redness in the surrounding skin and fever).\n* Patients who undertaking other therapies that could affect healing, such as corticosteroids, radiation therapy, or chemotherapy for cancer.\n* Heavy smoking (more than 20 cigarettes a day).\n* Concomitant chronic disease (e.g., diabetes mellitus or frank vascular disease such as Buerger's disease).\n* Patients who unable to continue the study because of death, discharge, or change in the care setting.","ALL","18 Years",{"count":79,"type":80},76,"ESTIMATED","INTERVENTIONAL",[83],"PHASE4","randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.",[86,87,88,89,90],"Pressure Injury","Pressure Injury Stage 2","Bedsore","Pressure Ulcers Stage II","Pressure Ulcer, Buttock",[92,93,94,95],"pressure injury","pressure ulcer","MEBO","Zinc oixid","2025-09-22",{"date":98,"type":99},"2025-09-26","ACTUAL",{"date":101,"type":99},"2023-12-31",{"date":103,"type":80},"2025-12-31",{"name":5,"class":6},2]